(Q38068839)

28 August 2017

1 reference

title

Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma (English)

1 reference

28 August 2017

Kara M Kelly

1

1 reference

28 August 2017

David Hodgson

2

1 reference

28 August 2017

Burton Appel

3

1 reference

28 August 2017

Lu Chen

4

1 reference

28 August 2017

Peter D Cole

5

1 reference

28 August 2017

Terzah Horton

6

1 reference

28 August 2017

Frank G Keller

7

1 reference

28 August 2017

COG Hodgkin Lymphoma Committee

8

1 reference

28 August 2017

publication date

19 December 2012

1 reference

28 August 2017

published in

Pediatric Blood & Cancer

1 reference

28 August 2017

volume

60

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

972-978

1 reference

Comparing adult and pediatric Hodgkin lymphoma in the Surveillance, Epidemiology and End Results Program, 1988-2005: an analysis of 21 734 cases

28 August 2017

cites work

1 reference

Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin's lymphoma--a report from the Children's Oncology Group

21 January 2018

1 reference

BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group

21 January 2018

1 reference

A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425.

21 January 2018

1 reference

Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study

21 January 2018

1 reference

Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma

21 January 2018

1 reference

Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group

21 January 2018

1 reference

Long-term survivors of childhood cancers in the United States

21 January 2018

1 reference

Chronic health conditions in adult survivors of childhood cancer

21 January 2018

1 reference

Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study

21 January 2018

1 reference

Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents.

21 January 2018

1 reference

Targetable molecular pathways in classical Hodgkin's lymphoma.

21 January 2018

1 reference

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas

21 January 2018

1 reference

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression

21 January 2018

1 reference

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

21 January 2018

1 reference

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

21 January 2018

1 reference

Virally targeted therapies for EBV-associated malignancies

21 January 2018

1 reference

Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4

21 January 2018

1 reference

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

21 January 2018

1 reference

Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report

21 January 2018

1 reference

Serum protein expression profiling in pediatric Hodgkin lymphoma: a report from the Children's Oncology Group.

21 January 2018

1 reference

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease

21 January 2018

1 reference

Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma

21 January 2018

1 reference

How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?

21 January 2018

1 reference

Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment

21 January 2018

1 reference

MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma

21 January 2018

1 reference

Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile

21 January 2018

1 reference

Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas

21 January 2018

1 reference

Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression

21 January 2018

1 reference

Virus-associated tumor imaging by induction of viral gene expression

21 January 2018

1 reference

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease

21 January 2018

1 reference

Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma

21 January 2018

1 reference

Report on the Third International Workshop on Interim Positron Emission Tomography in Lymphoma held in Menton, France, 26-27 September 2011 and Menton 2011 consensus.

21 January 2018

1 reference

High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group

21 January 2018

1 reference

Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group

21 January 2018

1 reference

Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients

21 January 2018

1 reference

A model-based estimate of cumulative excess mortality in survivors of childhood cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.24423

1 reference

28 August 2017

1 reference